About: Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.70 (+1.06%)
MIST NASDAQ Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc share price
Atividade de preço de MIST
Último preço
$ 0,700
Variação (24h)
0,01 USD (1,06%)
Volume
618.82K
Volume (média 4 sem.)
-
Abertura
$ 0,69
Variação do dia
$ 0,69 - $ 0,73
Fechamento anterior
$ 0,70
Último negócio
22 Oct, 8:00 pm GMT+0
Atrasado
22 Oct, 8:00 pm GMT+0
MIST price performance
Atrasado
22 Oct, 8:00 pm GMT+0
quote.marketSignals